BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 26453338)

  • 1. The Clinical Features of Myositis-Associated Autoantibodies: a Review.
    Gunawardena H
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):45-57. PubMed ID: 26453338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
    Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
    Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.
    Tiniakou E; Mammen AL
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):20-33. PubMed ID: 26429706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory myopathies and overlap syndromes: Update on histological and serological profile.
    Colafrancesco S; Priori R; Valesini G
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):810-25. PubMed ID: 27107515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis an evolving spectrum of disease.
    Barsotti S; Lundberg IE
    Immunol Med; 2018 Jun; 41(2):46-54. PubMed ID: 30938263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of myositis.
    Lundberg IE; de Visser M; Werth VP
    Nat Rev Rheumatol; 2018 May; 14(5):269-278. PubMed ID: 29651121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
    Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
    Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic inflammatory myopathies.
    van der Kooi AJ; de Visser M
    Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoantibodies of Inflammatory Myopathies: Update].
    Suzuki S
    Brain Nerve; 2016 Dec; 68(12):1443-1451. PubMed ID: 27916754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.
    Cavazzana I; Fredi M; Selmi C; Tincani A; Franceschini F
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):88-98. PubMed ID: 26514357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.